From: Surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung
Characteristic | Patients (n = 27) |
---|---|
Age | 73 (59–81) |
Sex | |
Male | 27 |
Female | 0 |
Pathology | |
Small | 22 |
LCNEC | 5 |
Smoking history (pack-years) | 46 (0–104) |
Maximum tumor diameter (mm) | 22 (11–48) |
Clinical stage | |
IA | 20 |
Small cell carcinoma 16 | |
LCNEC 4 | |
IB | 7 |
Small cell carcinoma 6 LCNEC 1 | |
Pathological stage | |
IA | 15 |
Small cell carcinoma 14 | |
LCNEC 1 | |
IB | 7 |
Small cell carcinoma 7 | |
LCNEC 0 | |
IIA | 2 |
Small cell carcinoma 1 | |
LCNEC 1 | |
IIB | 1 |
Small cell carcinoma 0 | |
LCNEC 1 | |
IIIA | 2 |
Small cell carcinoma 1 | |
LCNEC 1 | |
Preoperative Pro-GRP (pg/ml) | 43.4 (21.6–205) |
Operative procedure | |
Lobectomy | 21 |
Partial resection | 6 |
Adjuvant chemotherapy | 22 |
Interval from first visit operation (day) | 51 (27–159) |
Diagnosis before operation | 3 |